Inventor · disambiguated record
Michelle Dawn Garrett
Also filed as: GARRETT MICHELLE DAWN
6 granted patents·2 pending applications·19 citations·filing 2006–2020
79Inventor score
Files withASTEX THERAPEUTICS LTD2CANCER RESEARCH TECH LTD2THOMPSON NEIL THOMAS2CANCER RES TECH LTD1DAVIES THOMAS GLANMOR1
Top patents by PatentIndex Score
8 records- 0183US11787792B25-[[4-[[morpholin-2-yl]methylamino]-5-(trifluoromethyl)-2 Pyridyl]Amino]Pyrazine-2-carbonitrile and therapeutic uses thereofCANCER RESEARCH TECH LTD·Filed 2020·Granted Oct 17, 2023·1 cites·21 claims
- 0281US9663503B25-[[4-[[morpholin-2-yl]methylamino]-5-(trifluoromethyl)-2-pyridyl]amino]pyrazine-2-carbonitrile and therapeutic uses thereofCANCER RES TECH LTD·Filed 2013·Granted May 30, 2017·5 cites·19 claims
- 0380US8343953B2Pharmaceutical compoundsASTEX THERAPEUTICS LTD·Filed 2006·Granted Jan 1, 2013·6 cites·24 claims
- 0478US10259806B25-[[4-[[morpholin-2-yl]methylamino]-5-(trifluoromethyl)-2 pyridyl]amino]pyrazine-2-carbonitrile and therapeutic uses thereofCANCER RESEARCH TECH LTD·Filed 2017·Granted Apr 16, 2019·2 cites·16 claims
- 0576US8541461B2Pharmaceutical combinations comprising pyrazole derivatives as protein kinase modulatorsTHOMPSON NEIL THOMAS·Filed 2006·Granted Sep 24, 2013·2 cites·26 claims
- 0669US8796293B2Purine and deazapurine derivatives as pharmaceutical compoundsDAVIES THOMAS GLANMOR·Filed 2007·Granted Aug 5, 2014·3 cites·17 claims
- 0750US2009082370A1Pharmaceutical Combinations of PK Inhibitors and Other Active AgentsTHOMPSON NEIL THOMAS·Filed 2007·Application pending·0 cites
- 0844US2009253718A1Pharmaceutical CompoundsASTEX THERAPEUTICS LTD·Filed 2007·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →